SunOpta Inc. (STKL) Trading 5.7% Higher
Shares of SunOpta Inc. (NASDAQ:STKL) traded up 5.7% on Tuesday . The company traded as high as $5.69 and last traded at $5.54, with a volume of 731,287 shares traded. The stock had previously closed at $5.24.
A number of analysts have recently weighed in on the stock. AltaCorp Capital reaffirmed an “outperform” rating on shares of SunOpta in a report on Tuesday, June 21st. DA Davidson raised shares of SunOpta from a “neutral” rating to a “buy” rating and set a $6.00 price target for the company in a report on Wednesday, April 13th. Zacks Investment Research raised shares of SunOpta from a “sell” rating to a “hold” rating in a report on Wednesday, May 4th. Finally, Canaccord Genuity reaffirmed a “buy” rating and set a $10.00 price target on shares of SunOpta in a report on Wednesday, April 13th. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $9.50.
The stock has a 50-day moving average price of $4.74 and a 200-day moving average price of $4.98. The company’s market capitalization is $466.88 million.
SunOpta (NASDAQ:STKL) last announced its quarterly earnings data on Tuesday, May 10th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.04 by $0.01. The firm earned $352.30 million during the quarter, compared to the consensus estimate of $351.60 million. The business’s revenue was up 16.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.08 EPS. On average, equities analysts anticipate that SunOpta Inc. will post $0.24 earnings per share for the current year.
In other news, CEO Hendrik Jacobs bought 7,000 shares of the business’s stock in a transaction on Friday, May 20th. The shares were bought at an average cost of $3.85 per share, with a total value of $26,950.00. Following the purchase, the chief executive officer now directly owns 41,638 shares in the company, valued at $160,306.30. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Douglas Greene bought 50,000 shares of the business’s stock in a transaction on Friday, May 20th. The shares were purchased at an average cost of $3.77 per share, for a total transaction of $188,500.00. Following the completion of the purchase, the director now owns 265,543 shares in the company, valued at $1,001,097.11. The disclosure for this purchase can be found here.
Other institutional investors recently bought and sold shares of the company. Dimensional Fund Advisors LP increased its position in SunOpta by 56.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 151,928 shares of the company’s stock worth $1,039,000 after buying an additional 54,539 shares during the period. Jennison Associates LLC increased its position in SunOpta by 6.8% in the fourth quarter. Jennison Associates LLC now owns 4,234,596 shares of the company’s stock worth $28,965,000 after buying an additional 270,963 shares during the period. Baker Chad R bought a new position in SunOpta during the fourth quarter worth $2,977,000. Finally, Morgan Stanley increased its position in SunOpta by 123,646.6% in the fourth quarter. Morgan Stanley now owns 6,693,454 shares of the company’s stock worth $45,783,000 after buying an additional 6,688,045 shares during the period.
SunOpta Inc operates businesses focused on a healthy products portfolio. The Company operates through two segments: Global Ingredients and Consumer Products. Its Global Ingredients segment aggregates its North American and international raw material sourcing and supply operating segments focused on the procurement, processing and sale of specialty and organic grains and seeds, fruits, grain- and cocoa-based ingredients, and other commodities.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.